Lantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Book value per share
Lantheus Holdings, Inc.'s book value per share at the end of fiscal 2025 was 16.1×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 20.8×. Over the past ten years it has ranged from −7.6× (fiscal 2015) to 16.1× (fiscal 2025) — the current reading is the highest in ten years. Lantheus Holdings, Inc. ranks 7th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 16.1× | 2.70% |
| FY2024 | 15.7× | 31.55% |
| FY2023 | 12.0× | 83.06% |
| FY2022 | 6.5× | (5.13%) |
| FY2021 | 6.9× | (27.55%) |
| FY2020 | 9.5× | 223.15% |
| FY2019 | 2.9× | 58.28% |
| FY2018 | 1.9× | 197.23% |
| FY2017 | 0.6× | — |
| FY2016 | −3.3× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 20.8× | 3.13% |
| Jun 2026 | 20.1× | 7.50% |
| Mar 2026 | 18.7× | 15.97% |
| Dec 2025 | 16.1× | (3.00%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| LNTH Lantheus Holdings, Inc. | 20.8× |
| ALKS Alkermes plc compare | 11.1× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 9.1× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| LQDA Liquidia Corporation compare | 2.2× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 2.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 1.6× |
| HIMS Hims & Hers Health, Inc. compare | 1.4× |
| SUPN Indivior Pharmaceuticals Inc. compare | −0.5× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement